THE HEALTHCARE INTERVIEW
INTERVIEW WITH ABBOT ’ S
JENNIFER
JONES-MCMEANS
Jennifer Jones-McMeans , Divisional VP of Global Clinical Affairs at Abbott , discusses the importance of diversity in clinical trials
INTRODUCE YOURSELF AND YOUR ROLE AT ABBOTT .
» I ’ m Jennifer Jones-McMeans and I serve as the Divisional Vice President of Global Clinical Affairs for Abbott ’ s vascular business . For the past 14 years , I ’ ve worked on gaining approval for numerous medical devices . I also lead the new Diversity in Research Office at Abbott , where we focus on driving diversity in the company ’ s clinical trials and improving access to care among underrepresented populations .
PLEASE PROVIDE A BIT OF BACKGROUND ON ABBOTT ’ S CURRENT FOOTPRINT .
» At Abbott , we ’ re committed to creating and changing the future of healthcare through life-changing technologies and products that drive breakthroughs in prevention , diagnosis and treatment .
“ In my new role co-leading the Diversity in Research office , Abbott has identified a need to change the status quo of clinical trials ”
10 November 2023